The homolog of the five SH3-domain protein (HOFI/SH3PXD2B) regulates lamellipodia formation and cell spreading

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Lányi, Árpád ^a   Baráth, Mónika ^a   Péterfi, Zalán ^b   Bögel, Gábor ^b   Orient, Anna ^b   Simon, Tünde ^a   Petrovszki, Enikö ^a   Kis Tóth, Katalin ^a   Sirokmány, Gábor ^b   Rajnavölgyi, Éva ^a   Terhorst, Cox ^c   Buday, László ^b,d   Geiszt, Miklós ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c HARVARD MEDICAL SCHOOL   (United States)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CORTACTIN; EPIDERMAL GROWTH FACTOR; PROTEIN SH3PXD2B; PROTEIN TYROSINE KINASE; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; ACTIN; CTTN PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TKS4 PROTEIN, HUMAN;

ADIPOSE TISSUE; ARTICLE; BIOACCUMULATION; BONE DEVELOPMENT; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL MATURATION; CELL MEMBRANE; CELL SPREADING; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; EYE DEVELOPMENT; HUMAN; HUMAN CELL; LAMELLIPODIUM; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; CELL MOTION; CYTOLOGY; FIBROBLAST; HELA CELL; MACROPHAGE; METABOLISM; PROTEIN BINDING; PROTEIN TRANSPORT; PSEUDOPODIUM; SEQUENCE HOMOLOGY; SRC HOMOLOGY DOMAIN; UMBILICAL VEIN ENDOTHELIAL CELL;

ACTINS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL MOVEMENT; CORTACTIN; FIBROBLASTS; HELA CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; PHOSPHATIDYLINOSITOLS; PROTEIN BINDING; PROTEIN TRANSPORT; PSEUDOPODIA; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE HOMOLOGY, AMINO ACID; SRC HOMOLOGY DOMAINS;

EID: 84856007243     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023653     Document Type: Article

References (56)

1. Pawson T, (2007) Dynamic control of signaling by modular adaptor proteins. Curr Opin Cell Biol 19: 112-116.
2. Pullikuth AK, Catling AD, (2007) Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell Signal 19: 1621-1632.
3. Ushio-Fukai M, (2006) Localizing NADPH oxidase-derived ROS. Sci STKE 2006.
4. Balla T, (2005) Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J Cell Sci 118: 2093-2104.
5. Lock P, Abram CL, Gibson T, Courtneidge SA, (1998) A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate. Embo J 17: 4346-4357.
6. Oikawa T, Itoh T, Takenawa T, (2008) Sequential signals toward podosome formation in NIH-src cells. J Cell Biol 182: 157-169.
7. Seals DF, Azucena EF Jr, Pass I, Tesfay L, Gordon R, et al. (2005) The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 7: 155-165.
8. Calle Y, Burns S, Thrasher AJ, Jones GE, (2006) The leukocyte podosome. Eur J Cell Biol 85: 151-157.
9. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, et al. (2003) Cell migration: integrating signals from front to back. Science 302: 1704-1709.
10. Pollard TD, Borisy GG, (2003) Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465.
11. Small JV, Isenberg G, Celis JE, (1978) Polarity of actin at the leading edge of cultured cells. Nature 272: 638-639.
12. Svitkina TM, Borisy GG, (1999) Arp2/3 complex and actin depolymerizing factor/cofilin in dendritic organization and treadmilling of actin filament array in lamellipodia. J Cell Biol 145: 1009-1026.
13. Vignjevic D, Montagnac G, (2008) Reorganisation of the dendritic actin network during cancer cell migration and invasion. Semin Cancer Biol 18: 12-22.
14. Schuuring E, Verhoeven E, Litvinov S, Michalides RJ, (1993) The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol 13: 2891-2898.
15. Wu H, Parsons JT, (1993) Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 120: 1417-1426.
16. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ, et al. (2005) Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol 15: 1276-1285.
17. Huang C, Liu J, Haudenschild CC, Zhan X, (1998) The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem 273: 25770-25776.
18. Kowalski JR, Egile C, Gil S, Snapper SB, Li R, et al. (2005) Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 118: 79-87.
19. Patel AS, Schechter GL, Wasilenko WJ, Somers KD, (1998) Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16: 3227-3232.
20. Buday L, Downward J, (2007) Roles of cortactin in tumor pathogenesis. Biochim Biophys Acta 1775: 263-273.
21. Weaver AM, (2008) Cortactin in tumor invasiveness. Cancer Lett 265: 157-166.
22. Lai FP, Szczodrak M, Oelkers JM, Ladwein M, Acconcia F, et al. (2009) Cortactin promotes migration and platelet-derived growth factor-induced actin reorganization by signaling to Rho-GTPases. Mol Biol Cell 20: 3209-3223.
23. Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, et al. (2004) Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 41: 629-636.
24. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, et al. (2001) Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 61: 6906-6911.
25. Tsai WC, Jin JS, Chang WK, Chan DC, Yeh MK, et al. (2007) Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters. J Histochem Cytochem 55: 955-962.
26. Buschman MD, Bromann PA, Cejudo-Martin P, Wen F, Pass I, et al. (2009) The Novel Adaptor Protein Tks4 (SH3PXD2B) Is Required for Functional Podosome Formation. Mol Biol Cell.
27. Gianni D, Diaz B, Taulet N, Fowler B, Courtneidge SA, et al. (2009) Novel p47(phox)-related organizers regulate localized NADPH oxidase 1 (Nox1) activity. Sci Signal 2: ra54.
28. Gianni D, Taulet N, Dermardirossian C, Bokoch GM, (2010) c-Src-mediated Phosphorylation of NoxA1 and Tks4 Induces the Reactive Oxygen Species (ROS)-dependent Formation of Functional Invadopodia in Human Colon Cancer Cells. Mol Biol Cell 21: 4287-4298.
29. Hishida T, Eguchi T, Osada S, Nishizuka M, Imagawa M, (2008) A novel gene, fad49, plays a crucial role in the immediate early stage of adipocyte differentiation via involvement in mitotic clonal expansion. Febs J 275: 5576-5588.
30. Iqbal Z, Cejudo-Martin P, de Brouwer A, van der Zwaag B, Ruiz-Lozano P, et al. (2010) Disruption of the podosome adaptor protein TKS4 (SH3PXD2B) causes the skeletal dysplasia, eye, and cardiac abnormalities of Frank-Ter Haar Syndrome. Am J Hum Genet 86: 254-261.
31. Mao M, Thedens DR, Chang B, Harris BS, Zheng QY, et al. (2009) The podosomal-adaptor protein SH3PXD2B is essential for normal postnatal development. Mamm Genome 20: 462-475.
32. Abram CL, Seals DF, Pass I, Salinsky D, Maurer L, et al. (2003) The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem 278: 16844-16851.
33. Blouw B, Seals DF, Pass I, Diaz B, Courtneidge SA, (2008) A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. Eur J Cell Biol 87: 555-567.
34. David-Pfeuty T, Singer SJ, (1980) Altered distributions of the cytoskeletal proteins vinculin and alpha-actinin in cultured fibroblasts transformed by Rous sarcoma virus. Proc Natl Acad Sci U S A 77: 6687-6691.
35. White MK, Weber MJ, (1988) Transformation by the src oncogene alters glucose transport into rat and chicken cells by different mechanisms. Mol Cell Biol 8: 138-144.
36. Johnson D, Frame MC, Wyke JA, (1998) Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence. Oncogene 16: 2017-2028.
37. Turner CE, (2000) Paxillin interactions. J Cell Sci 113 Pt 23: 4139-4140.
38. Ammer AG, Weed SA, (2008) Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil Cytoskeleton 65: 687-707.
39. Wunderlich L, Goher A, Farago A, Downward J, Buday L, (1999) Requirement of multiple SH3 domains of Nck for ligand binding. Cell Signal 11: 253-262.
40. Illes A, Enyedi B, Tamas P, Balazs A, Bogel G, et al. (2006) Cortactin is required for integrin-mediated cell spreading. Immunol Lett 104: 124-130.
41. Seet LF, Hong W, (2006) The Phox (PX) domain proteins and membrane traffic. Biochim Biophys Acta 1761: 878-896.
42. Bravo J, Karathanassis D, Pacold CM, Pacold ME, Ellson CD, et al. (2001) The crystal structure of the PX domain from p40(phox) bound to phosphatidylinositol 3-phosphate. Mol Cell 8: 829-839.
43. Kanai F, Liu H, Field SJ, Akbary H, Matsuo T, et al. (2001) The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nat Cell Biol 3: 675-678.
44. Gimona M, Buccione R, Courtneidge SA, Linder S, (2008) Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol 20: 235-241.
45. Machesky LM, (2008) Lamellipodia and filopodia in metastasis and invasion. FEBS Lett 582: 2102-2111.
46. Zhan Y, He D, Newburger PE, Zhou GW, (2004) p47(phox) PX domain of NADPH oxidase targets cell membrane via moesin-mediated association with the actin cytoskeleton. J Cell Biochem 92: 795-809.
47. Zhan Y, Virbasius JV, Song X, Pomerleau DP, Zhou GW, (2002) The p40phox and p47phox PX domains of NADPH oxidase target cell membranes via direct and indirect recruitment by phosphoinositides. J Biol Chem 277: 4512-4518.
48. Daly RJ, (2004) Cortactin signalling and dynamic actin networks. Biochem J 382: 13-25.
49. Lynch DK, Winata SC, Lyons RJ, Hughes WE, Lehrbach GM, et al. (2003) A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J Biol Chem 278: 21805-21813.
50. Campbell DH, Sutherland RL, Daly RJ, (1999) Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res 59: 5376-5385.
51. van Damme H, Brok H, Schuuring-Scholtes E, Schuuring E, (1997) The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J Biol Chem 272: 7374-7380.
52. Kelley LC, Hayes KE, Ammer AG, Martin KH, Weed SA, (2010) Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence. PLoS One 5: e13847.
53. Rethi B, Gogolak P, Szatmari I, Veres A, Erdos E, et al. (2006) SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells. Blood 107: 2821-2829.
54. Adam Z, Adany R, Ladanyi A, Timar J, Balazs M, (2000) Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p. Clin Exp Metastasis 18: 295-302.
55. Illes A, Enyedi B, Tamas P, Balazs A, Bogel G, et al. (2006) Inducible phosphorylation of cortactin is not necessary for cortactin-mediated actin polymerisation. Cell Signal 18: 830-840.
56. Tamas P, Solti Z, Bauer P, Illes A, Sipeki S, et al. (2003) Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac. J Biol Chem 278: 5163-5171.